Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers
NCT01932437
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Inhalational Anthrax
Interventions
BIOLOGICAL:
ETI-204
OTHER:
Placebo
Sponsor
Elusys Therapeutics